Expression of angiotensinogen and receptors for angiotensin and prorenin in the monkey and human substantia nigra: An intracellular renin-angiotensin system in the nigra

Brain Structure and Function

Volumn 218, Issue 2, 2013, Pages 373-388

  Garrido Gil, Pablo ^a,c   Valenzuela, Rita ^a,c   Villar Cheda, Begoña ^a,c   Lanciego, Jose L ^b,c   Labandeira Garcia, Jose L ^a,c  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^b UNIVERSITY OF NAVARRA   (Spain)

^c CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED SOBRE ENFERMEDADES NEURODEGENERATIVAS CIBERNED   (Spain)

Author keywords

Angiotensin; Basal ganglia; Dopamine; Intracrine; Neurodegeneration; Parkinson

Indexed keywords

ANGIOTENSIN RECEPTOR; ANGIOTENSINOGEN; PRORENIN RECEPTOR;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CONFOCAL MICROSCOPY; DOPAMINERGIC NERVE CELL; GLIA CELL; HAPLORHINI; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOREACTIVITY; MALE; MICROGLIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SUBSTANTIA NIGRA PARS COMPACTA; UPREGULATION;

ADULT; ANGIOTENSINOGEN; ANIMALS; ASTROCYTES; AUTOPSY; DOPAMINERGIC NEURONS; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; MACACA FASCICULARIS; MALE; MICROGLIA; MICROSCOPY, CONFOCAL; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ANGIOTENSIN, TYPE 2; RECEPTORS, CELL SURFACE; RENIN-ANGIOTENSIN SYSTEM; SUBSTANTIA NIGRA; VACUOLAR PROTON-TRANSLOCATING ATPASES;

ANIMALIA; RODENTIA;

EID: 84878860958     PISSN: 18632653     EISSN: 18632661     Source Type: Journal    
DOI: 10.1007/s00429-012-0402-9     Document Type: Article

References (70)

1. Allen AM, MacGregor DP, Chai SY, Donnan GA, Kaczymarzyk S, Richardson K, Kalnins R, Ireton J, Mendelsohn FAO (1992) Angiotensin II receptor binding associated with nigrostriatal dopaminergic neurons in human basal ganglia. Ann Neurol 32:339-344
2. Allen AM, Moeller I, Jenkins A, Zhuo J, Aldred GP, Chai SY, Mendelsohn FAO (1998) Angiotensin receptors in the nervous system. Brain Res Bull 47:17-18
3. Baker KM, Chernin MI, Schreiber T, Sanghi S, Haiderzaidi S, Booz GW, Dostal DE, Kumar R (2004) Evidence of a novel intracrine mechanism in angiotensin II-induced cardiac hypertrophy. Regul Pept 120:5-13
4. Benigni A, Corna D, Zoja C, Sonzogni A, Latini R, Salio M, Conti S, Rottoli D, Longaretti L, Cassis P, Morigi M, Coffman TM, Remuzzi G (2009) Disruption of the Ang II type 1 receptor promotes longevity in mice. J Clin Invest 119:524-530
5. Chabrashvili T, Kitiyakara C, Blau J, Karber A, Islam S, Welch WJ, Wilcox CF (2003) Effect of Ang II type 1 and 2 receptors on oxidative stress, renal NAD(P)H oxidase, and SOD expression. Am J Physiol Regu Integr Comp Physiol 285:R117-R124
6. Chen R, Mukhin YV, Garnovskaya MN, Thielen TE, Iijima Y, Huang C, Raymond JR, Ullian ME, Paul RV (2000) A functional angiotensin II receptor-GFP fusion protein: evidence for agonist-dependent nuclear translocation. Am J Physiol Renal Physiol 279:F440-F448
7. Cuadra AE, Shan Z, Sumners C, Raizada MK (2010) A current view of brain renin-angiotensin system: Is the (pro)renin receptor the missing link? Pharmacol Ther 125:27-38
8. Dzau VJ, Brenner A, Emmett NL (1982) Evidence for renin in rat brain: differentiation from other renin like enzymes. Am J Physiol 242:E292-E297
9. Eggena P, Zhu JH, Sereevinyayut S, Giordani M, Clegg K, Andersen PC, Hyun P, Barrett JD (1996) Hepatic angiotensin II nuclear receptors and transcription of growth-related factors. J Hypertens 14:961-968
10. Fuxe K, Ganten D, Hökfelt T, Locatelli V, Poulsen K, Stock G, Rix E, Taugner R (1980) Renin-like immunocytochemical activity in the rat and mouse brain. Neurosci Lett 18:245-250
11. Ganong WF (1994) Origin of the angiotensin II secreted by cells. Proc Soc Exp Biol Med 205:213-219
12. Ganten D, Minnich JL, Granger P, Hayduk K, Brecht HM, Barbeau A, Boucher R, Genest J (1971) Angiotensin-forming enzyme in brain tissue. Science 173(991):64-65
13. Garrido AM, Griendling KK (2009) NADPH oxidases and angiotensin II receptor signaling. Mol Cell Endocrinol 302(2):148-158
14. Gildea JJ (2009) Dopamine and angiotensin as renal counterregulatory systems controlling sodium balance. Curr Opin Nephrol Hypertens 18:28-32
15. González-Hernández T, Cruz-Muros I, Afonso-Oramas D, Salas-Hernandez J, Castro-Hernandez J (2010) Vulnerability of mesostriatal dopaminergic neurons in Parkinson's disease. Front Neuroanat 4:140
16. Griendling KK, Sorescu D, Ushio-Fukai M (2000) NADPH oxidase. Role in cardiovascular biology and disease. Circ Res 86:494-501
17. Joglar B, Rodriguez-Pallares J, Rodríguez-Perez AI, Rey P, Guerra MJ, Labandeira-Garcia JL (2009) The inflammatory response in the MPTP model of Parkinson's disease is mediated by brain angiotensin: relevance to progression of the disease. J Neurochem 109:656-669
18. Jones ES, Vinh A, McCarthy CA, Gaspari TA, Widdop RE (2008) AT2 receptors: functional relevance in cardiovascular disease. Pharmacol Ther 120(3):292-316
19. Kehoe PG, Wilcock GK (2007) Is inhibition of the renin-angiotensin system a new treatment option for Alzheimer's disease? Lancet Neurol 6(4):373-378
20. Khan F, Spicarová Z, Zelenin S, Holtbäck U, Scott L, Aperia A (2008) Negative reciprocity between angiotensin II type 1 and dopamine D1 receptors in rat renal proximal tubule cells. Am J Physiol Renal Physiol 295:F1110-F1116
21. Konings CH, Kuiper MA, Bergmans PL, Grijpma AM, van Kamp GJ, Wolters EC (1994) Increased angiotensin-converting enzyme activity in cerebrospinal fluid of treated patients with Parkinson's disease. Clin Chim Acta 23:101-106
22. Kumar A, Rassoli A, Raizada MK (1988) Angiotensinogen gene expression in neuronal and glial cells in primary cultures of rat brain. J Neurosci Res 19:287-290
23. Kumar R, Singh VP, Baker KM (2007) The intracellular renin-angiotensin system: a new paradigm. Trends Endocrinol Metab 18(5):208-214
24. Kumar R, Singh VP, Baker KM (2009) The intracellular renin-angiotensin system in the heart. Curr Hypertens Rep 11(2):104-110
25. Lanz TV, Ding Z, Ho PP, Luo J, Agrawal AN, Srinagesh H, Axtell R, Zhang H, Platten M, Wyss-Coray T, Steinman L (2010) Angiotensin II sustains brain inflammation in mice via TGF-beta. J Clin Invest 120(8):2782-2794
26. Lavoie JL, Cassell MD, Gross KW, Sigmund CD (2004) Localization of renin expressing cells in the brain, by use of a REN-eGFP transgenic model. Physiol Genomics 16:240-246
27. 2) receptor mRNAs in the adult rat brain: a functional neuroanatomical review. Front Neuroendocrinol 18:383-439
28. Li J, Culman J, Hortnagl H, Zhao Y, Gerova N, Timm M, Blume A, Zimmermann M, Seidel K, Dirnagl U, Unger T (2005) Angiotensin AT2 receptor protects against cerebral ischemia-induced neuronal injury. FASEB J 19:617-619
29. Li H, Armando I, Yu P, Escano C, Mueller SC, Asico L, Pascua A, Lu Q, Wang X, Villar VA, Jones JE, Wang Z, Periasamy A, Lau YS, Soares-da-Silva P, Creswell K, Guillemette G, Sibley DR, Eisner G, Gildea JJ, Felder RA, Jose PA (2008) Dopamine 5 receptor mediates Ang II type 1 receptor degradation via a ubiquitin-proteasome pathway in mice and human cells. J Clin Invest 118:2180-2189
30. Lin JJ, Yueh KC, Chang DC, Lin SZ (2002) Association between genetic polymorphism of angiotensin-converting enzyme gene and Parkinson disease. J Neurol Sci 199:25-29
31. Lopez-Real A, Rey P, Soto-Otero R, Mendez-Alvarez E, Labandeira-Garcia JL (2005) Angiotensin-converting enzyme inhibitors reduce oxidative stress and protect dopaminergic neurons in a 6-hydroxydopamine rat model of parkinsonism. J Neurosci Res 81:865-873
32. Lou M, Blume A, Zhao Y, Gohlke P, Deuschl G, Herdegen T, Culman J (2004) Sustained blockade of brain AT1 receptors before and after focal cerebral ischemia alleviates neurologic deficits and reduces neuronal injury, apoptosis, and inflammatory responses in the rat. J Cereb Blood Flow Metab 24:536-547
33. Lu D, Yang H, Shaw G, Raizada MK (1998) Angiotensin II-induced nuclear targeting of the angiotensin type 1 (AT1) receptor in brain neurons. Endocrinology 139:365-375
34. Luetscher JA, Kraemer FB, Wilson DM, Schwartz HC, Bryer-Ash M (1985) Increased plasma inactive renin in diabetes mellitus. A marker of microvascular complications. N Engl J Med 312:1412-1417
35. Miles JM, Chou SM (1988) A new immunoperoxidase marker for microglia in paraffin section. J Neuropathol Exp Neurol 47(6):579-587
36. Milsted A, Barna BP, Ransohoff RM, Brosnihan KB, Ferrario CM (1990) Astrocyte cultures derived from human brain tissue express angiotensinogen mRNA. Proc Natl Acad Sci USA 87:5720-5723
37. Mogi M, Horiuchi M (2009) Effects of angiotensin II receptor blockers on dementia. Hypertens Res 32(9):738-740
38. Muñoz A, Rey P, Guerra MJ, Mendez-Alvarez E, Soto-Otero R, Labandeira-Garcia JL (2006) Reduction of dopaminergic degeneration and oxidative stress by inhibition of angiotensin converting enzyme in a MPTP model of parkinsonism. Neuropharmacology 51:112-120
39. Münzel T, Keany JF (2001) Are ACE inhibitors a "magic bullet" against oxidative stress? Circulation 104:1571-1577
40. Nguyen G (2011) Renin, (pro)renin and receptor: an update. Clin Sci (Lond) 120(5):169-178
41. Nguyen G, Delarue F, Burcklé C, Bouzhir L, Giller T, Sraer JD (2002) Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin. J Clin Invest 109:1417-1427
42. Phillips MI, de Oliveira EM (2008) Brain renin angiotensin in disease. J Mol Med 86:715-722
43. Quinlan JT, Phillips MI (1981) Immunoreactivity for angiotensin II-like peptide in the human brain. Brain Res 205:212-218
44. Re RN (2003) Intracellular renin and the nature of intracrine enzymes. Hypertension 42:117-122
45. Re RN (2004) Tissue renin angiotensin systems. Med Clin North Am 88:19-38
46. Rey P, Lopez-Real A, Sanchez-Iglesias S, Muñoz A, Soto-Otero R, Labandeira-Garcia JL (2007) Angiotensin type-1-receptor antagonists reduce 6-hydroxydopamine toxicity for dopaminergic neurons. Neurobiol Aging 28:555-567
47. Rodriguez-Pallares J, Quiroz CR, Parga JA, Guerra MJ, Labandeira-Garcia JL (2004) Angiotensin II increases differentiation of dopaminergic neurons from mesencephalic precursors via angiotensin type 2 receptors. Eur J Neurosci 20:1489-1498
48. Rodriguez-Pallares J, Rey P, Parga JA, Muñoz A, Guerra MJ, Labandeira-Garcia JL (2008) Brain angiotensin enhances dopaminergic cell death via microglial activation and NADPH-derived ROS. Neurobiol Dis 31:58-73
49. Rodriguez-Perez AI, Valenzuela R, Villar-Cheda B, Guerra MJ, Lanciego JL, Labandeira-Garcia JL (2010) Estrogen and angiotensin interaction in the substantia nigra. Relevance to postmenopausal Parkinson's disease. Exp Neurol 224:517-526
50. Rodriguez-Perez AI, Valenzuela R, Joglar B, Garrido-Gil P, Guerra MJ, Labandeira-Garcia JL (2011) Renin angiotensin system and gender differences in dopaminergic degeneration. Mol Neurodegener 6(1):58
51. Rodriguez-Perez AI, Valenzuela R, Villar-Cheda B, Guerra MJ, Labandeira-Garcia JL (2012) Dopaminergic neuroprotection of hormonal replacement therapy in young and aged menopausal rats. Role of the brain angiotensin system. Brain 135:124-138
52. Ruiz-Ortega M, Lorenzo O, Ruperez M, Suzuki Y, Egido J (2001) Proinflammatory actions of angiotensin II. Curr Opin Nephrol Hypertens 10:321-329
53. Saavedra JM (2005) Brain angiotensin II: new developments, unanswered questions and therapeutic opportunities. Cell Mol Neurobiol 25:485-512
54. Savaskan E (2005) The role of the brain renin-angiotensin system in neurodegenerative disorders. Curr Alzheimer Res 2(1):29-35
55. Simonnet G, Giorguieff-Chesselet MF, Carayon A, Bioulac B, Cesselin F, Glowinski J, Vincent JD (1981) Angiotensin II and the nigrostriatal system. J Physiol (Paris) 77:71-79
56. Slater EE, Defendini R, Zimmerman EA (1980) Wide distribution of immunoreactive renin in nerve cells of human brain. Proc Natl Acad Sci USA 77:5458-5460
57. Smith Y, Villalba R (2008) Striatal and extrastriatal dopamine in the basal ganglia: an overview of its anatomical organization in normal and Parkinsonian brains. Mov Disord 23(Suppl 3):S534-S547
58. Stegbauer J, Lee DH, Seubert S, Ellrichmann G, Manzel A, Kvakan H, Muller DN, Gaupp S, Rump LC, Gold R, Linker RA (2009) Role of the renin-angiotensin system in autoimmune inflammation of the central nervous system. Proc Natl Acad Sci USA 106(35):14942-14947
59. Stornetta RL, Hawelu-Johnson CL, Guyenet PG, Lynch KR (1988) Astrocytes synthesize angiotensinogen in brain. Science 242:1444-1446
60. Suzuki Y, Ruiz-Ortega M, Lorenzo O, Ruperez M, Esteban V, Egido J (2003) Inflammation and angiotensin II. Int J Biochem Cell Biol 35:881-900
61. Thomas WG, Greenland KJ, Shinkel TA, Sernia C (1992) Angiotensinogen is secreted by pure rat neuronal cell cultures. Brain Res 588:191-200
62. Touyz RM (2004) Reactive oxygen species and angiotensin II signaling in vascular cells-implications in cardiovascular disease. Braz J Med Biol Res 37:1263-1273
63. Unger T, Chung O, Csikos T, Culman J, Gallinat S, Gohlke P, Höhle S, Meffert S, Stoll M, Stroth U, Zhu Y-Z (1996) Angiotensin receptors. J Hypertens Suppl 14(5):S95-S103
64. Valenzuela R, Barroso-Chinea P, Muñoz A, Joglar B, Villar-Cheda B, Lanciego JL, Labandeira-Garcia JL (2010) Location of prorenin receptors in primate substantia nigra. Effects on dopaminergic cell death. J Neuropathol Exp Neurol 69(11):1130-1142
65. Verina T, Kiihl SF, Schneider JS, Guilarte TR (2011) Manganese exposure induces microglia activation and dystrophy in the substantia nigra of non-human primates. Neurotoxicology 32(2):215-226
66. Villar-Cheda B, Rodríguez-Pallares J, Muñoz A, Valenzuela R, Guerra MJ, Baltatu OC, Labandeira-Garcia JL (2010) Nigral and striatal regulation of angiotensin receptor expression by dopamine and angiotensin in rodents: implications for progression of Parkinson's disease. Eur J Neurosci 32:1695-1706
67. Villar-Cheda B, Valenzuela R, Rodriguez-Perez AI, Guerra MJ, Labandeira-Garcia JL (2012) Aging-related changes in the nigral angiotensin system enhances proinflammatory and pro-oxidative markers and 6-OHDA-induced dopaminergic degeneration. Neurobiol Aging 33(1):204.e1-11
68. Wright JW, Harding JW (2011) Brain renin-angiotensin - a new look at an old system. Prog Neurobiol 95:49-67
69. Zalba G, San Jose G, Moreno MU, Fortuño MA, Fortuño A, Beaumont FJ, Diez J et al (2001) Oxidative stress in arterial hypertension. Role of NADPH oxidase. Hypertension 38:1395-1399
70. Zeng C, Liu Y, Wang Z, He D, Huang L, Yu P, Zheng S, Jones JE, Asico LD, Hopfer U, Eisner GM, Felder RA, Jose PA (2006) Activation of D3 dopamine receptor decreases angiotensin II type 1 receptor expression in rat renal proximal tubule cells. Circ Res 99:494-500